Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00636090 · ClinicalTrials.gov registry record
Molecular, Genetic, and Genomic Assessments From Patients Treated With RAD001
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 35
- Enrollment target
NCT00636090: Completed study, sponsored by Duke University.
NCT00636090 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 35 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00636090 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 35 participants
- Enrollment target
Study Summary
The purpose of this study is to look at the genetic changes that RAD001 causes in prostate cancer cells and how those changes relate to patients' response to RAD001 treatment.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2007-01 |
| Est. Completion | 2010-01 |
What the finished NCT00636090 record still lists
NCT00636090 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 35 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00636090 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00636090 about?
NCT00636090 is a clinical study titled "Molecular, Genetic, and Genomic Assessments From Patients Treated With RAD001". The purpose of this study is to look at the genetic changes that RAD001 causes in prostate cancer cells and how those changes relate to patients' response to RAD001 treatment.
What is the current status of trial NCT00636090?
This trial is currently completed. The enrollment target is 35 participants. The study started on 2007-01. Estimated completion is 2010-01.
Who is sponsoring clinical trial NCT00636090?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia